Cambridge Investment Research Advisors
AMTX icon

Cambridge Investment Research Advisors’s Aemetis AMTX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AMTX Stock Details AMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,020
Closed -$165K – 3050
2022
Q1 		$165K Hold
13,020
– – ﹤0.01% 2927
2021
Q4 		$160K Buy
+13,020
New +$230K ﹤0.01% 2949
2021
Q1 		– Sell
-10,000
Closed -$25K – 2865
2020
Q4 		$25K Hold
10,000
– – ﹤0.01% 2675
2020
Q3 		$32K Hold
10,000
– – ﹤0.01% 2472
2020
Q2 		$8K Buy
+10,000
New +$7.27K ﹤0.01% 2447

Other funds holding AMTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Cambridge Investment Research Advisors's AMTX Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of Aemetis (AMTX) in Q2 2022, closing a stake of 13,020 shares — an estimated $165K sold.

Cambridge Investment Research Advisors first reported a position in AMTX in Q2 2020 and held it in 5 quarters. The position peaked at $165K in Q1 2022. 83 funds tracked by Wall St. Rank hold AMTX as of Q2 2022.

  • Cambridge Investment Research Advisors reported no remaining Aemetis position as of Q2 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 13,020 Aemetis shares in Q2 2022, an estimated $165K.
  • Cambridge Investment Research Advisors first reported a position in Aemetis in Q2 2020 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's Aemetis position peaked at $165K in Q1 2022.
  • 83 funds tracked by Wall St. Rank held Aemetis as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.